Prot #GS-US-218-1797: A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients with Respiratory Syncytial Virus (RSV) Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date8/29/168/29/19

Funding

  • PPD Development (GS-US-218-1797)
  • Gilead Sciences, Inc. (GS-US-218-1797)